| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMA/715767/2013 (22.11.13) |
| Publication Date | 22/11/2013 |
| Content Type | News |
|
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in November 2013, recommended granting a marketing authorisation for Tivicay in combination with other antiretroviral medicines for the treatment of adults and adolescents over 12 years of age infected with human immunodeficiency virus (HIV). |
|
| Source Link | http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001973.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |
